Business Wire

ISL

14.10.2019 12:51:06 CEST | Business Wire | Press release

Share
‘Energy’ Pulses Through Superstar Swimmers in International Swimming League Leg in Naples

The second and final day of the International Swimming League’s first tour of Europe proved to be the most exciting of the young season thus far, as a sold out crowd at the Piscina Felipe Scandone in Naples, Italy, were treated to a pair of tight club battles that came down to the final event.

The passion of the European fans was very evident to those competing, giving them a boost late in the match.

“It's really cool how great this has been unfolding,” said Cali Condor’s Caeleb Dressel , who was named MVP with a match-high 57.5 points. “Again this is my first meet, but everyone loved Indy. And this is, I think, even a step up from that because it's in Europe this time. I think the fans are a little bit crazier, a little bit better, a little bit more into it.”

"This is a whole other level of things. I mean, the crowd for one, but the lights, the DJ, the walkout, it makes it seem like an event. Not just something that you get to watch, but you feel like you're a part of it.”

“The energy on deck, I can still feel it right now as I'm sitting here,” said DC Trident captain Cody Miller in a post-match media scrum. “It was awesome, it was a lot of fun, and I think that there's just more greatness to come. It was so, so fun.”

Another thing that stood out to Miller was the noise, which was exaggerated due to the way the building was constructed.

"I think probably cause the pool is mostly made of concrete...the noise! I have not been to many facilities where the noise is that awesome, it makes it fun. It makes it fun for us, it makes it fun for people that are watching,” said Miller enthusiastically.

“I think that makes a big difference with the energy levels,” said Energy Standard male captain Chad Le Clos on how the crowd impacted the match. “Doing back-to-back races - 50 fly, 200 fly, 100 freestyle - getting back up (on the blocks) was very special, and a big thank you to the crowd. Altogether it was a great show.”

DC Trident coach Cyndi Gallagher had a similar perspective as the athletes, really enjoying the vibe that the match produced.

“I think this is super fun, exciting,” Gallagher said in an interview during one of the breaks. “I love the crowd, I love that they're getting the crowd into it, the music, the DJ, our energy is great. We are all in.”

Sarah Sjostrom , a Swede who is one of the sport’s biggest stars in Europe, always loves swimming in front of an Italian crowd.

"They love the Italian swimmers, but they do love the other swimmers as well,” said the 2016 Olympic gold medalist. “The other swimming stars, even if you're from Sweden. I always love racing in Italy. So it's a lot of fun to have very good supporters here in the stands.”

The match was tightly contested for first place between Energy Standard, who won last weekend in Indianapolis, and the Cali Condors, who received a significant boost with Dressel making his debut.

Dressel went out and won the final event, the men’s skins, which are worth triple the points. However, his Energy Standard counterparts Florent Manaudou and Ben Proud placed second and third to secure another win for their club.

"It hurts. I mean, I'd much rather have a team title than MVP, 100 percent of the time,” said Dressel, who won a total of four individual events over the two days. “It definitely stings, but it's cool, there's already started (to be) rivalries (developing) and stuff. Of course, friendly rivalries. I respect everyone on that team, but I would've liked to win the meet. And it was so close which is what makes it hurt a little bit more.”

The 23-year-old is confident the Condors will continue to improve and have a good chance of winning it all at the league grand final in Vegas in December.

“I could've been better throughout the meet and scored more points, we all could've been, everyone across the board. We're on a good progression for now, from Indy to here, so we'll find some more room to be better, and then hopefully by Vegas we'll have it figured out.”

Miller’s Trident club was locked in a close race with the hometown Aqua Centurions, going back and forth throughout the match in the race for third.

“We have two teams, my team (DC Trident) and the Aqua Centurions, vying for just a few points here and there. It feels like it's an NBA game. It feels like a basketball game,” he said. “We were a ways behind the two front-running teams, but were still in a tight race with another team, so, it's exciting.”

“There's a rivalry. It's a good rivalry, It's been fun.”

About the ISL: The International Swimming League is a global professional swimming competition launching in 2019 with teams in both Europe (Italy-based Aqua Centurions, France-based Energy Standard, Hungary-based Iron, and London Roar) and the United States (Cali Condors, DC Trident, LA Current, NY Breakers). The inaugural season will include matches in Indianapolis IN, Naples ITA, Lewisville TX, Budapest HUN, College Park MD, London GBR, and the championship finale at the 12,000-seat Mandalay Bay Events Center in Las Vegas, NV. The ISL aims to create groundbreaking projects, in both form and content, exploring the full potential of competitive swimming while securing sustainable commercial growth in the sport.

Key Dates:
5-6 October 2019 – IU Natatorium, Indianapolis, USA
12-13 October 2019 – Aquatic Swimming Complex, Naples, Italy
19-20 October 2019 – The LISD Westside Aquatic Center, Lewisville, Texas, USA
26-27 October 2019 – Duna Area, Budapest, Hungary
16-17 November 2019 – Natatorium at the Eppley Recreation Center, Maryland, USA
23-24 November 2019 – London Aquatic Centre, Great Britain
20-21 December 2019 – Mandalay Bay Resort and Casino, Las Vegas, USA

ISL SOCIAL: Keep up with all the latest ISL news by following @iswimleague on Instagram and Twitter and @internationalswimmingleague on Facebook. Visit https://isl.global
For latest images, video and stories go to http://apmultimedianewsroom.com/multimedia-newsroom/partners/international-swimming-league

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release

Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release

Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie

IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release

IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi

Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release

Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye